AUS
NZ
UK
CA
USA
IND
Healthcare
Doximity's Capital Initiatives Signal Long-Term Growth
September 29, 2024 08:24 AM PDT| By Team Kalkine MediaHeadlines,Doximity's capital strategy suggests promising growth, highlighting its ability to reinvest profits effectively.,Return on Capital Employed (ROCE) reflects strong efficiency in Doximity's use of its capital.,Doximity’s ongoing reinvestment...
Pfizer Sees a Modest Increase in Trading Activity
September 28, 2024 12:15 AM PDT| By Team Kalkine MediaHeadlines,Pfizer's stock price saw a slight uptick in Friday's trading session.,Recent analyst ratings suggest mixed views on Pfizer, with some upgrades and price target adjustments.,Trading volume for Pfizer decreased significantly compared to its a...
New Era in Schizophrenia Care with Bristol Myers Squibb's COBENFY Approval
September 27, 2024 12:22 PM PDT| By Team Kalkine MediaHighlights,Bristol Myers Squibb's shares rose following the FDA's approval of COBENFY, the first new schizophrenia treatment in decades.,The medication, a twice-daily pill, targets specific brain receptors and aims to reduce symptoms significantly.,T...
Dynamic Forces Fueling Advancement in the Healthcare Sector
September 27, 2024 11:17 AM PDT| By Team Kalkine MediaHighlights,The Materials sector has shown strong performance recently, prompting interest in high-growth technology stocks for potential capital appreciation.,Alvotech is advancing in the biotechnology field with plans to expand its biosimilar offeri...
SpringWorks Therapeutics Navigates Challenges Amid Revenue Growth
September 27, 2024 11:15 AM PDT| By Team Kalkine MediaHighlights,SpringWorks Therapeutics has faced a recent decline in share price, contrasting with its significant appreciation over the past five years.,Despite reporting a loss recently, the company has demonstrated strong revenue growth, outpacing ty...
PureTech Health Celebrates FDA Approval of Cobenfy: A Milestone in Schizophrenia Treatment
September 27, 2024 07:18 AM PDT| By Team Kalkine MediaPureTech Health plc (Nasdaq: PRTC, LSE: PRTC) has achieved a significant milestone with the FDA's recent approval of Cobenfy (xanomeline and trospium chloride) for the treatment of schizophrenia in adults. This groundbreaking approval not only signif...
Tonix Pharmaceuticals Secures New Patent for Zembrace® SymTouch® in Migraine Treatment
September 27, 2024 07:05 AM PDT| By Team Kalkine MediaTonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP), a fully-integrated biopharmaceutical company, recently announced a significant milestone in its mission to combat migraine disorders. On September 24, 2024, the United States Patent and Trademark Of...
Dupixent® Gains NMPA Approval for COPD Treatment in China: A New Hope for Patients
September 27, 2024 06:56 AM PDT| By Team Kalkine MediaThe National Medical Products Administration (NMPA) in China has granted approval for Dupixent® (dupilumab) as an add-on maintenance treatment for adults suffering from uncontrolled chronic obstructive pulmonary disease (COPD) characterized by elevat...
Immunic Develops Pipeline of Oral Therapies for Chronic Inflammatory and Autoimmune Diseases
September 27, 2024 05:50 AM PDT| By Team Kalkine MediaHighlights,Immunic Inc,(NASDAQ:IMUX),is advancing its lead asset, vidofludimus calcium, currently in Phase 3 trials for multiple sclerosis, with promising data presented at the ECTRIMS Congress.,The drug has shown potential to reduce neurofilament li...
Hemogenyx Pharmaceuticals Ready to Commence Phase I Trial
September 27, 2024 03:35 AM PDT| By Team Kalkine MediaHighlights,Hemogenyx Pharmaceuticals is nearing the launch of a phase I trial for HEMO-CAR-T, a treatment for acute myeloid leukaemia (AML), at the MD Anderson Center in Texas.,The company is also advancing its CBR platform and CDX program, targeting...
Molina Healthcare Achieves Impressive Shareholder Growth
September 26, 2024 02:00 PM PDT| By Team Kalkine MediaHeadlines,Molina Healthcare has delivered remarkable shareholder returns, with a significant increase in stock value over the last five years.,The company has experienced consistent earnings growth, contributing to positive market perceptions.,Invest...
Pfizer Experiences Slight Decline in Trading
September 26, 2024 01:31 PM PDT| By Team Kalkine MediaHeadlines,Pfizer Inc. experienced a modest decline in stock price, trading at approximately $28.76.,Several brokerages have adjusted their target prices, with a mix of ratings reflecting varied perspectives on the stock’s performance.,Analyst opinion...
NanoViricides Partners with TheraCour for Antiviral Development
September 26, 2024 12:42 PM PDT| By Team Kalkine MediaHighlights,NanoViricides has signed a Memorandum of Understanding with TheraCour Pharma, granting it first refusal rights on all antiviral drug developments, enhancing access to essential intellectual property.,The collaboration supports the advancem...
Why Nevro Stands Out as a Strong Growth Candidate
September 26, 2024 12:41 PM PDT| By Team Kalkine MediaHeadlines,Nevro is positioned for growth due to advancements in its Senza product and an expanding product portfolio.,Ongoing research and development efforts are expected to drive future performance.,The company has consistently outperformed earning...
Emergent Bio Soars Following U.S. Government Order for Smallpox Therapy
September 26, 2024 12:15 PM PDT| By Team Kalkine MediaHeadlines,Emergent Bio's stock sees an uptick due to recent government contracts.,The order for smallpox therapy highlights the increasing demand for biodefense products.,Investors are keenly watching the company’s growth in the public health sector....
CASI Pharmaceuticals Faces Recent Decline After Robust Year
September 26, 2024 12:01 PM PDT| By Team Kalkine MediaHighlights,CASI Pharmaceuticals has faced a significant share price decline this week, yet it has achieved impressive annual returns, indicating ongoing shareholder optimism.,The company has not been profitable recently and experienced a notable reve...
Belite Bio Navigates Cash Challenges in Quest for Biotech Breakthrough
September 26, 2024 09:48 AM PDT| By Team Kalkine MediaHighlights,Southwest Airlines' shares surged after updating its third-quarter revenue forecast in the airline sector.,The airline introduced a three-year plan including assigned seating and premium options to enhance services.,Expanding partnerships...
Patterson Companies Expands Animal Health Division with Strategic Acquisitions in the U.K. and U.S.
September 26, 2024 04:04 AM PDT| By Team Kalkine MediaPatterson Companies, Inc. (Nasdaq:PDCO), a prominent distribution company in the dental and animal health sectors, has announced significant strides in its Animal Health business through two separate acquisition agreements. The company will acquire I...
.jpg)
Enanta Pharmaceuticals Reports Promising Phase 2a Results for EDP-323 in RSV Treatment
September 26, 2024 04:00 AM PDT| By Team Kalkine MediaEnanta Pharmaceuticals, Inc. (NASDAQ: ENTA), a clinical-stage biotechnology company focused on developing innovative small molecule drugs for virology and immunology, has announced encouraging topline results from a Phase 2a human challenge study of...
Eli Lilly Rises Toward Market Milestone with Innovative Drug Advances
September 25, 2024 01:37 PM PDT| By Team Kalkine MediaHighligths,Eli Lilly's shares are nearing all-time highs, driven by recent FDA approvals and strong revenue growth from its GLP-1 drugs, which have significantly boosted sales.,The company has raised its revenue guidance and continues to prioritize s...
